Apr4 | Brooks Laboratories` directors resign Brooks Laboratories` directors resign
With effect from 02 April 2013
The board of Brooks Laboratories in its meeting on 02 April 2013 has
accepted the resignation of Anil Khanna and Harsh Bhalla as independent
directors of the company with effect from 02 April 2013. |
Dec24 | Brooks Laboratories appoints additional director Brooks Laboratories appoints additional director
With effect from 01 December 2012
A resolution was passed by circulation effected on 01 December 2012 whereby
Harsh Bhalla was appointed as additional independent director of Brooks
Laboratories with effect from 01 December 2012. |
Jun29 | Brooks Laboratories appoints director Brooks Laboratories appoints director
With immediate effect
The board of Brooks Laboratories in its meeting on 28 June 2012 has
approved the appointment of Anil Khanna as additional independent director
with immediate effect. |
May23 | Brooks Laboratories appoints directors Brooks Laboratories appoints directors
With immediate effect
The board of Brooks Laboratories in its meeting on 23 May 2012 has
appointed Rajnish Kumar Bedi and Dinesh Puri as additional independent
directors of the company with immediate effect. |
Jan30 | Brooks Laboratories` directors resign Brooks Laboratories` directors resign
With effect from 06 January 2012
The board of Brooks Laboratories in its meeting on 28 January 2012 has
accepted the resignation of Vivek Sharma, Lalit Mahajan and Monika
Sabharwal, directors of the company with effect from 06 January 2012. |
Jan25 | Brooks Laboratories to hold board meeting Brooks Laboratories to hold board meeting
On 28 January 2012
The board meeting of Brooks Laboratories will be held on 28 January 2012 to
accept the resignation of independent directors of the company. |
Jan9 | Brooks Laboratories` directors resign Brooks Laboratories` directors resign
With effect from 06 January 2012
Brooks Laboratories has announced that Monika Sabharwal, Vivek Sharma and
Lalit Mahajan, directors have resigned from the board of the company with
effect from 06 January 2012. |
Dec14 | Brooks Laboratories to hold board meeting Brooks Laboratories to hold board meeting
On 17 December 2011
The board meeting of Brooks Laboratories will be held on 17 December 2011
to consider and approve the alternation, amendment, variation and revision
of site pertaining to the proposed project mentioned in the prospectus
dated 22 August 2011 and to shift the registered office of the company,
from one state to another state. |
Dec8 | Brooks Laboratories receives approval for manufacture of Doripenem Monohydrate Injection Brooks Laboratories receives approval for manufacture of Doripenem
Monohydrate Injection
From Directorate General of Health Service
Brooks Laboratories has announced that the company has received approval
for manufacture of Doripenem Monohydrate Injection from Directorate General
of Health Service. The company is all set to manufacture this drug within
this fiscal year.
Doripenem is a broad spectrum anti-bacterial agent of carbapenem family.
Growing bacterial resistance is major cause of concern for researchers as
it contributors to increase in mortality, morbidity and treatment cost.
Doripenem is an ultra broad spectrum anti bacterial agent of carbepenem
family used to treat in complicated intra-abdominal infections and
complicated urinary tract infections, including complicated and
uncomplicated pylenephritis and cases with concurrent bacteremia. |
Nov16 | Brooks Laboratories to hold board meeting Brooks Laboratories to hold board meeting
On 19 November 2011
The board meeting of Brooks Laboratories will be held on 19 November 2011
to discuss and decide regarding the loan to Mr. Rajesh Mahajan, managing
director and Awl Ranchal, whole-time director of the company. |
Sep20 | Brooks Laboratories appoints CEO & CFO Brooks Laboratories appoints CEO & CFO
With effect from 19 September 2011
The board of Brooks Laboratories in its meeting on 19 September 2011 has
appointed D S Maity as chief executive officer of the company with effect
from 19 September 2011.
Further, the board has appointed Ketan Shah as chief financial officer of
the company with effect from 19 September 2011. |